A risk of serious anaphylatic reactions to asthma biologics: a pharmacovigilance study based on a global real-world database

Asthma is a chronic inflammatory condition that affects the lung airways. Chronic use of oral glucocorticoids in patients with severe asthma is associated with several adverse events (AEs). Biologics (omalizumab, benralizumab, mepolizumab, reslizumab, and dupilumab) have been developed as alternativ...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Sunny, Kim, Yeju, Lee, Geon Ho, Choi, Soo An
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582024/
https://www.ncbi.nlm.nih.gov/pubmed/37848636
http://dx.doi.org/10.1038/s41598-023-44973-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582024/
https://www.ncbi.nlm.nih.gov/pubmed/37848636
http://dx.doi.org/10.1038/s41598-023-44973-z

Ejemplares similares